IP Library › Granted Patent US 10,870,825
Granted Patent B2
US 10,870,825 · App. 16/794,603 · Granted Dec 22, 2020

Pulsatile perfusion bioreactor for mimicking, controlling, and optimizing blood vessel mechanics

Inventors: John F. Eberth (Columbia, SC); Tarek Shazly (Columbia, SC); Boran Zhou (Columbia, SC); David A. Prim (Columbia, SC); Conrad Michael Gore (West Columbia, SC)
Assignee: University of South Carolina
C12M29/12C12M21/08C12M25/10C12M29/00C12M29/10C12M35/04C12M41/40C12N5/0691
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 10,870,825
App. No.
16/794,603
Granted
Dec 22, 2020
Kind
B2
Abstract

A pulsatile perfusion bioreactor for culturing one or more engineered blood vessels having a lumen and a wall is provided. The bioreactor includes a chamber for holding the engineered blood vessel and cell culture media; a mechanical property monitoring system for measuring axial tensile stress and strain, circumferential tensile stress and strain, and/or shear stress imparted on the vessel wall; and a pump system for delivering cell culture media through the vessel lumen, wherein the vessel is exposed to a composite pressure waveform and a composite flow waveform as the media is delivered there through. The pump system includes a steady flow and peristaltic pumps. Further, the composite pressure and flow waveforms each include a mean component, a fundamental frequency component, and a second harmonic frequency component. The bioreactor also includes a computer interface for monitoring and adjusting the composite waveforms to maintain a predetermined stress level.

Claims (12)

1. A method of culturing an engineered blood vessels having a lumen and a wall inside a pulsatile perfusion bioreactor, the method comprising:

inserting the engineered blood vessel to be cultured into a chamber;

filling the chamber with cell culture media;

delivering cell culture media through the lumen of the engineered blood vessel via a pump system, wherein the engineered blood vessel is exposed to a composite pressure waveform and a composite flow waveform as the cell culture media is delivered through the lumen, the pump system comprising a steady flow pump and a peristaltic pump, wherein the composite pressure waveform comprises a mean pressure component, a first harmonic frequency pressure component, and a second harmonic frequency pressure component, and wherein the composite flow waveform component comprises a mean flow component, a first harmonic frequency flow component, and a second harmonic frequency flow component;

measuring axial tensile stress, circumferential tensile stress, shear stress, axial stretch, circumferential stretch, or a combination thereof imparted on the wall of the engineered blood vessel via a mechanical property monitoring system;

monitoring and adjusting the composite pressure waveform, the composite flow waveform, or a combination thereof to maintain a predetermined axial tensile stress level, a predetermined circumferential stress level, a predetermined shear stress level, a predetermined axial stretch level, a predetermined circumferential stretch level, or a combination thereof via a computer interface.

2. The method as in claim 1 , wherein the composite pressure waveform and the composite flow waveform are derived from a pressure waveform and a flow waveform of a native blood vessel, wherein the engineered blood vessel is a replacement for the native blood vessel.

3. The method as in claim 2 , wherein the pulsatile perfusion bioreactor includes a compliance chamber, wherein the compliance chamber facilitates adjustment of the composite pressure waveform.

4. The method as in claim 2 , wherein pressure is measured via a pressure transducer and a stepper motor controlled pinch valve is utilized to adjust resistance within the pulsatile perfusion bioreactor, wherein adjusting the resistance results in an adjustment to the pressure.

5. The method as in claim 1 , wherein the steady flow pump delivers the mean pressure component of the composite pressure waveform and the mean flow component of the composite flow waveform.

6. The method as in claim 1 , wherein the peristaltic pump delivers a pulsatile flow of cell culture media through the lumen, wherein the peristaltic pump comprises a first pump head and a second pump head, wherein the first pump head provides the first harmonic frequency pressure component of the composite pressure waveform and the first harmonic frequency flow component of the composite flow waveform, and wherein the second pump head provides the second harmonic frequency pressure component of the composite pressure waveform and the second harmonic frequency flow component of the composite flow waveform.

7. The method as in claim 6 , wherein the peristaltic pump further comprises a third pump head, wherein the third pump head provides a third harmonic frequency pressure component of the composite pressure waveform and a third harmonic frequency flow component of the composite flow waveform.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Feb 19, 2020
From: EBERTH, JOHN F.; SHAZLY, TAREK; ZHOU, BORAN; PRIM, DAVID A.; GORE, CONRAD MICHAEL
To: UNIVERSITY OF SOUTH CAROLINA
Reel/Frame 051858/0226 →
Continuity (3)
Division 15071354 · Mar 16, 2016
Provisional Application 62143844 · Apr 7, 2015
Related Publication 20200181556A1 · Jun 11, 2020